SLC12A2 and cancer: These have been associated partly with ion homeostasis disruption via NKCC1 inhibition and/or the targeting of anion exchangers.12 Ion channels and transporters represent targets of growing interest since they appear to be involved in cancer development, chemoresistance and migration4,31–33.